School of Medicine
Showing 21-30 of 98 Results
-
Millie Das
Clinical Professor, Medicine - Oncology
BioDr. Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and is an active member of the VA national Lung Cancer Working Group and Lung Cancer Precision Oncology Program. In 2023, she was elected President the Association of Northern California Oncologists (ANCO), where she displays her passion for patient advocacy and also for clinician education by helping to organize Bay Area focused continuing medical education programs. She is the VA site director for the Stanford fellowship program and leads the VA thoracic tumor board on a biweekly basis. She has a strong interest in clinical research, serving as a principal investigator for multiple clinical and translational studies at the Palo Alto VA, and also as a co-investigator on all of the lung cancer trials at Stanford. In her free time, she enjoys spending time with her family, traveling, and running.
-
James C. Dickerson, MD MS
Clinical Assistant Professor, Medicine - Oncology
BioDr. Dickerson is a medical oncologist in the Division of Medical Oncology at Stanford University School of Medicine, specializing in the care of patients with breast cancer. In addition to seeing patients in the clinic, he researches how health policy, data science, and emerging technologies can improve cancer care delivery. His research group focuses on three core objectives: (1) developing financially sustainable cancer care programs, (2) analyzing large clinical and administrative datasets to identify gaps where policy can improve equity and outcomes, and (3) conducting clinical and implementation research to determine the most effective ways to deliver high-quality, evidence-based oncology care.
Across these objectives, Dr. Dickerson integrates traditional real-world data analytics with modern natural language processing approaches, including large language models, to study cancer care delivery. His group develops and applies LLM-based tools to improve the extraction, structuring, and interpretation of complex clinical information from electronic health records, to enhance clinical decision-making, care coordination, and health policy evaluation.
Dr. Dickerson received his undergraduate degree from Vanderbilt University and graduated magna cum laude from the University of Mississippi Medical Center. He completed his internship and residency in Internal Medicine at Stanford University, followed by fellowship training in Hematology and Oncology. During his fellowship, Dr. Dickerson earned a Master’s degree in Health Policy and completed post-doctoral research in the Department of Health Policy. -
Milana V. Dolezal, MD, MSci
Clinical Associate Professor, Medicine - Oncology
BioDr. Dolezal is a board-certified hematologist-oncologist with Stanford Medicine Cancer Center in Emeryville and a clinical associate professor in the Stanford School of Medicine, Division of Oncology.
She strives to work with patients to develop care plans that are comprehensive and personalized achieve the best possible outcomes and quality of life.
Dr. Dolezal also has extensive experience in research and drug development. She previously held positions as a clinical scientist, assistant medical director, and associate medical director in the BioOncology Therapeutics unit of the biotechnology company Genentech.
She has conducted clinical research into fertility preservation in patients with breast cancer, advanced treatments for triple-negative breast cancer, and patients’ adherence to anti-cancer therapy. She has co-authored articles on her research findings that appeared in the Journal of Clinical Oncology, Cancer, and other peer-reviewed publications.
She also co-authored the chapter “Progression from Hormone-Dependent to Hormone-Independent Breast Cancer” in the textbook Hormones, Genes and Cancer published by Oxford University Press.
Dr. Dolezal has made presentations to her peers at meetings of the American Association for Cancer Research, American Society of Clinical Oncology, and European Cancer Organisation. -
Timothy John Ellis-Caleo
Clinical Assistant Professor, Medicine - Oncology
BioDr. Timothy Ellis-Caleo is a board-certified medical oncologist and clinical assistant professor of medicine at Stanford University. His clinical expertise center on thoracic and GI malignancies. He completed his undergraduate training in Physics at Washington University in St. Louis and earned his MD from the David Geffen School of Medicine at UCLA where he was a Geffen Scholar and Alpha Omega Alpha inductee. He completed both internal medicine residency and hematology/oncology fellowship at Stanford University. Dr. Ellis-Caleo’s research has been published Nature Communications, Nature Cancer, and the Journal of Thoracic Disease. He currently sees patients at Stanford’s Emeryville location and welcomes the chance to contribute to the care of patients throughout the Bay Area.
-
Alice C. Fan
Associate Professor of Medicine (Oncology) and, by courtesy, of Urology
Current Research and Scholarly InterestsDr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
-
Dean W. Felsher
Professor of Medicine (Oncology) and of Pathology
Current Research and Scholarly InterestsMy laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.
-
George A. Fisher Jr.
Colleen Haas Chair in the School of Medicine, Emeritus
Current Research and Scholarly InterestsClinical expertise in GI cancers with research which emphasizes Phase I and II clinical trials of novel therapies but also includes translational studies including biomarkers, molecular imaging, tumor immunology and development of immunotherapeutic trials.
-
James Ford
Professor of Medicine (Oncology) of Genetics and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNA damage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer.
-
Kristen N Ganjoo
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsGiant cell tumor of the bone
Gastrointestinal stromal tumors
Soft tissue sarcoma
Osteosarcoma
